Nuvalent, Inc. (NUVL)

104.26 -1.90 (-1.79%) USD  |  NASDAQ  |  Jan 16, 16:00
104.36 +0.10 (+0.10%) After-Hours: 20:00
More

Nuvalent Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Pfizer Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Xencor, Inc. Upgrade
Glaukos Corp. Upgrade